Physician profile
Leslie Fullerton
NPI 1437311909
$4,132.98
in general payments reported to CMS, 2019-2025
8 companies · $1,710 in 2025
The $1,710 reported for 2025 was more than what 94% of Orthodontics and Dentofacial Orthopedics providers received nationally (typical 2025 total: $146).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $546 · 2020: $153 · 2021: $344 · 2022: $312 · 2023: $555 · 2024: $512 · 2025: $1,710.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $1,662 · Consulting Fee: $1,116.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $1,661.60 |
| Consulting Fee | $1,115.95 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Envista Holdings Corporation | $2,220.49 | 2024-2025 | Ultima, Spark, Damon |
| Ormco Corporation | $702.24 | 2020-2023 | Damon, Spark |
| American Orthodontics Corporation | $378.74 | 2019-2022 | |
| 3m Company | $323.44 | 2019-2021 | |
| Nobel Biocare USA | $261.58 | 2023 | Nobelactive |
| Align Technology, INC. | $216.82 | 2020-2023 | Invisalign |
| Philips North America LLC | $27.37 | 2019-2020 | |
| USA Angelalign Technology Corp | $2.30 | 2025 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Leslie Fullerton listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.